Who is sponsoring NCT04142853?

NCT04142853 is sponsored by Hasselt University.

What drugs are being tested in NCT04142853?

Interventions in NCT04142853: Training intervention + Dance intervention.

What condition does NCT04142853 study?

NCT04142853 studies Multiple Sclerosis.

Is NCT04142853 still recruiting?

NCT04142853 is currently completed. Last updated 1 June 2020.

Last reviewed 2020-06-01 · How we verify

NCT04142853

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Underlying Causes and Related Factors, and Rehabilitation Approaches

Completed NA Last updated 1 June 2020

What this trial tests

NA trial testing Training intervention + Dance intervention in Multiple Sclerosis in 40 participants. Completed in 31 December 2019.

Timeline

1 March 2019

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	40
Start date	1 March 2019
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	2 locations across Belgium

Drugs / interventions tested

Training intervention + Dance intervention

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Hasselt University

Who can join

Adults 18 to 70, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a cross-sectional observational study, followed by a pilot intervention. The aim of the study is to examine the underlying causes of walking-related performance fatigability, together with other related and influencing factors, to make up a clinical profile of patients with MS showing walking-related performance fatigability. In the second part of the study a pilot intervention will be executed to see if the investigators can improve the clinical status of the MS patients with walking-related performance fatigability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interlimb Coordination Performance in Seated Position in Persons With Multiple Sclerosis: Reduced Amplitude Over 6 min and Higher Coordination Variability in Persons With Walking Fatigability.
Goetschalckx M, Van Geel F, Meesen R, Triccas LT, et al · · 2021 · cited 1× · PMID 34744669 · DOI 10.3389/fnhum.2021.765254

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Hasselt University trials

Trials by the same sponsor.

NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04142853 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hasselt University
Last refreshed: 1 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04142853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing